Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | AGXT | P21549 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.40 |
| ▸ | CES1 | P23141 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL27525496 | 0.84 | PTPN1 (0.43) | TSHRPTPN1KDM4EPOLBALDH1A1 | |
| SCHEMBL16559626 | 0.83 | IDO1 (0.47) | IDO1AGXTALDH1A1MAOB | |
| SCHEMBL3434137 | 0.81 | TSHR (0.48) | TSHRIDO1AGXTPTPN1ALDH1A1 | |
| SCHEMBL22346842 | 0.81 | TSHR (0.54) | TSHRIDO1AGXTPTPN1KDM4E | |
| SCHEMBL11192334 | 0.79 | TSHR (0.46) | TSHRIDO1AGXTPTPN1KDM4E | |
| SCHEMBL23227683 | 0.79 | TSHR (0.52) | TSHRIDO1AGXTPTPN1KDM4E | |
| SCHEMBL11526962 | 0.79 | ALDH1A1 (0.53) | ALDH1A1SLC6A2SLC6A3LMNACYP2C19 | |
| SCHEMBL10591074 | 0.78 | IDO1 (0.50) | IDO1KDM4EALDH1A1CA2SLC6A2 | |
| SCHEMBL7590606 | 0.78 | IDO1 (0.54) | IDO1AGXTCA1CA2CA9 | |
| SCHEMBL10523360 | 0.78 | TSHR (0.44) | TSHRIDO1AGXTPTPN1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 339 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122012034-A | Cooling liquid, liquid cooling module and electronic equipment | 华为技术有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-119638588-A | Trifluoromethyl benzyl ether substituted amino acid derivative, preparation method and application thereof | 中国医学科学院药物研究所 | 2025-03-18 | — | — | CN | claimed |
| CN-118994765-A | Insulation and pressure-resistant material for cable | 安徽朗达电线电缆有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-117895064-B | Phosphate polymer quasi-solid electrolyte, in-situ solid immobilization preparation method and application | 深圳大学 | 2024-11-19 | — | — | CN | claimed |
| CN-118325411-B | Antifouling paint composition and preparation method thereof | 广州翔铭环保新材料有限公司 | 2024-08-09 | — | — | CN | claimed |
| CN-118325411-A | Antifouling paint composition and preparation method thereof | 广州翔铭环保新材料有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-117895064-A | Phosphate polymer quasi-solid electrolyte, in-situ solid immobilization preparation method and application | 深圳大学 | 2024-04-16 | — | — | CN | claimed |
| CN-115784839-A | Preparation method of 4-cyclohexyl-3- (trifluoromethyl) benzyl alcohol | 浙江工业大学 | 2023-03-14 | — | — | CN | claimed |
| CN-113999342-B | Migratable polymer-based functional modifier and preparation method and application thereof | 厦门大学 | 2022-08-12 | — | — | CN | claimed |
| US-20220033634-A1 | CURABLE FLUORINE-BASED ELASTOMER COMPOSITE AND CURED PRODUCT THEREOF | 3M INNOVATIVE PROPERTIES COMPANY | 2022-02-03 | — | — | US | claimed |
| WO-2007139933-A2 | PROCESSES FOR THE PREPARATION OF R-(+)-3-(CARBAMOYL METHYL)-5-METHYLHEXANOIC ACID AND SALTS THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2007-12-06 | — | — | WO | claimed |
| US-6979690-B2 | Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators | PFIZER INC. (US) | 2005-12-27 | — | — | US | claimed |
| CN-1226258-C | Process for producing fluorinated methyl-benzyl alcohol | SHOWAN DENKO K K (JP) | 2005-11-09 | — | — | CN | claimed |
| EP-1017692-B1 | 4-HETEROARYL-TETRAHYDROQUINOLINES AND THEIR USE AS INHIBITORS OF THE CHOLESTERIN-ESTER TRANSFER PROTEIN | BAYER HEALTHCARE AG (DE) | 2004-03-03 | — | — | EP | claimed |
| CN-1466560-A | Process for producing fluorinated methyl-benzyl alcohol | �Ѻ͵繤��ʽ���� | 2004-01-07 | — | — | CN | claimed |
| US-20030207875-A1 | Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators | PFIZER INC | 2003-11-06 | — | — | US | claimed |
| WO-2003057688-A2 | OXO OR OXY-PYRIDINE COMPOUNDS AS 5-HT4 RECEPTOR MODULATORS | PFIZER JAPAN INC. (JP) | 2003-07-17 | — | — | WO | claimed |
| EP-1325921-A2 | Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators | Pfizer Inc. (US) | 2003-07-09 | — | — | EP | claimed |
| WO-1993012080-A1 | SUBSTITUTED DIPHENYLSULFIDES AS SEROTONIN UPTAKE INHIBITORS | THE WELLCOME FOUNDATION LIMITED (GB) | 1993-06-24 | — | — | WO | claimed |
| EP-0271780-A2 | Substituted 1-benzylsulfonyl-3-heteroaryl(thio) urea | BAYER AG (DE) | 1988-06-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207875-A1 | Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators | HRH4, HRH2, HTR4 | TSHR 148/4885IDO1 560/4885AGXT 4285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.